335 related articles for article (PubMed ID: 1204244)
1. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
McLean RH; Townsend K; Michael AF
Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
[TBL] [Abstract][Full Text] [Related]
2. Studies of the alternate pathway in chelated serum.
Forsgren A; Mclean RH; Michael AF; Quie PG
J Lab Clin Med; 1975 Jun; 85(6):904-12. PubMed ID: 805816
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of activation of the properdin system. Studies on properdin electrophoretic mobility in agarose activation of the alternative pathway.
Adam C; Williams DG; Peters DK
Clin Exp Immunol; 1975 Nov; 22(2):240-8. PubMed ID: 813932
[TBL] [Abstract][Full Text] [Related]
4. Complement activation in semi-solid medium: Insolubilization of properdin and the third component of complement (C3) in agar gels.
Ziegler JB; Watson L; Goodkofsky I; Alper CA; Lepow IH
J Immunol; 1976 Jan; 116(1):75-9. PubMed ID: 812917
[TBL] [Abstract][Full Text] [Related]
5. Properdin deficiency in a family with fulminant meningococcal infections.
Sjöholm AG; Braconier JH; Söderström C
Clin Exp Immunol; 1982 Nov; 50(2):291-7. PubMed ID: 7151327
[TBL] [Abstract][Full Text] [Related]
6. The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation.
Lachmann PJ; Halbwachs L
Clin Exp Immunol; 1975 Jul; 21(1):109-14. PubMed ID: 52423
[TBL] [Abstract][Full Text] [Related]
7. Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.
Gigli I; Koethe S; Austen KF
Clin Immunol Immunopathol; 1975 Jul; 4(2):189-98. PubMed ID: 1170051
[No Abstract] [Full Text] [Related]
8. C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus.
Wild JH; Zvaifler NJ; Müller-Eberhard HJ; Wilson CB
Clin Exp Immunol; 1976 May; 24(2):238-48. PubMed ID: 1084239
[TBL] [Abstract][Full Text] [Related]
9. Evidence that C1s participates in the alternative complement pathway.
Volanakis JE; Schultz DR; Stroud RM
Int Arch Allergy Appl Immunol; 1976; 50(1):68-80. PubMed ID: 1244208
[TBL] [Abstract][Full Text] [Related]
10. Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.
Ruley EJ; Forristal J; Davis NC; Andres C; West CD
J Clin Invest; 1973 Apr; 52(4):896-904. PubMed ID: 4693654
[TBL] [Abstract][Full Text] [Related]
11. Covalent linkage of C3 to properdin during complement activation.
Whiteman LY; Purkall DB; Ruddy S
Eur J Immunol; 1995 May; 25(5):1481-4. PubMed ID: 7774654
[TBL] [Abstract][Full Text] [Related]
12. A properdin system intermediate formed by zymosan and serum at 0 degrees C.
Yukiyama Y; Lew FT; Waks HS; Osler AG
J Immunol; 1976 Jan; 116(1):188-93. PubMed ID: 812914
[TBL] [Abstract][Full Text] [Related]
13. The modulation of the alternative pathway of complement in C2-deficient human serum by changes in concentration of the component and control proteins.
Nydegger UE; Fearon DT; Austen KF
J Immunol; 1978 Apr; 120(4):1404-8. PubMed ID: 565382
[No Abstract] [Full Text] [Related]
14. Dissociation of anticomplementary and adjuvant properties of proteins derived from cobra venom.
Morrison DC; Louis JA; Weigle WO
Immunology; 1976 Mar; 30(3):317-23. PubMed ID: 56310
[TBL] [Abstract][Full Text] [Related]
15. Complement activation in semisolid media: insolubilization of alternative pathway convertases in agar gels with C3 nephritic factor-containing sera.
Arnaout MA; Davis AE; Rosen RS; Alper CA
J Immunol; 1977 Oct; 119(4):1316-20. PubMed ID: 894039
[TBL] [Abstract][Full Text] [Related]
16. [Role of the classical and alternative complement pathways in chemotaxis of human C2 deficiency (author's transl)].
Pham Huu T; Buriot D; Griscelli C
Ann Immunol (Paris); 1980; 131C(1):69-77. PubMed ID: 7396417
[TBL] [Abstract][Full Text] [Related]
17. Activation of the alternative pathway of complement in childhood acute lymphoblastic leukemia.
Kalwinsky DK; Urmson JR; Stitzel AE; Spitzer RE
J Lab Clin Med; 1976 Nov; 88(5):745-56. PubMed ID: 1068203
[TBL] [Abstract][Full Text] [Related]
18. Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system.
Perrin LH; Shiraishi S; Stroud RM; Lambert PH
J Immunol; 1975 Jul; 115(1):32-5. PubMed ID: 1171140
[TBL] [Abstract][Full Text] [Related]
19. Alternative pathway of complement in sickle cell disease.
Strauss RG; Asbrock T; Forristal J; West CD
Pediatr Res; 1977 Apr; 11(4):285-9. PubMed ID: 846782
[TBL] [Abstract][Full Text] [Related]
20. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
Densen P; McRill CM; Ross SC
J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
